Advertisement
Advertisement
AKBA
Akebia Therapeutics, Inc.
0.93
USDSponsored
-0.05
-4.84%
Sep 23, 15:59 UTC -4
Closed
After-Market
0.94
0.00
+0.36%
Akebia Therapeutics, Inc. Financial Snapshot
| Market Cap | 259.37M |
| Beta | 0.19 |
| Earnings Per Share (EPS) | -0.11 |
| Price-to-Book (P/B) Ratio | 10.06 |
| Operating Margin | -12.84% |
| Total Debt/Equity (D/E) | 198.11% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -88.88% |
| Current Ratio | 1.43% |
| Free Cash Flow | -18.82M |
